fatty liver disease — grants

Sort

16,300 grants matching “fatty liver disease”

Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes

$620,404

Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies

$620,254

Joshua Wiley Knowles · Stanford University · R01 · FY2023 · DK

Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

$619,776

Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2025 · DK

HIV Therapy & Interruption RCT in Resource Poor Clinic

$619,730

Luis J. Montaner · Wistar Institute · U01 · FY2007 · AI

Ethnicity and fat deposition in obesity-related disease in youth

$619,583

Vicente Gilsanze · University Of Southern California · P60 · FY2009 · MD

Deep phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 human knockouts and population based studies

$619,439

Danish Saleheen · Columbia University Health Sciences · R01 · FY2022 · HL

HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY

$619,264

Cecilia M Shikuma · University Of Hawaii At Manoa · UH3 · FY2024 · MD

Non Alcoholic Steatohepatitis Clinical Research Network

$618,611

Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · DK

Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseases

$618,159

Alexander Revzin · Mayo Clinic Rochester · R01 · FY2024 · DK

Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies

$617,918

Joshua Wiley Knowles · Stanford University · R01 · FY2022 · DK

Randomized Trial of Diet in GDM: Metabolic Consequences to Mother and Offspring

$617,819

Teri L Hernandez · University Of Colorado Denver · R01 · FY2015 · DK

Transgenerational obesity caused by ancestral exposure to obesogens in utero: changes in germline genomic architecture, roles of gonadal somatic cells, and metabolomic analysis of sexual dimorphism

$617,630

Bruce Blumberg · University Of California-Irvine · R01 · FY2018 · ES

Visceral Adiposity, HIV, and HCV: Biologic Mediators of Hepatic Steatosis

$617,477

Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2012 · AI

Novel roles of PDK4 in regulating mitochondrial protein phosphorylation, carbon flux and metabolic resilience

$617,385

Deborah M Muoio · Duke University · R01 · FY2024 · DK

Effects of Macronutrients on Regulation of Endoplasmic Reticulum Stress in Human

$617,334

Guenther Boden · Temple Univ Of The Commonwealth · R01 · FY2012 · DK

Metabolic effects of adipose lipogenesis

$617,321

Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2014 · DK

Metabolic effects of adipose lipogenesis

$617,321

Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2015 · DK

Prenatal stress and diet, and the fetal epigenome

$617,209

Cathrine Hoyo · North Carolina State University Raleigh · R01 · FY2024 · MD

Perfluoroalkyl Substances and the Gut Microbiome and Fecal Metabolome: Implications for Obesity Risk in Hispanic Children

$617,027

Tanya Lynn Alderete · Johns Hopkins University · R01 · FY2024 · ES

Heat shock protein 90 in alcoholic liver disease: targeting macrophage Function

$616,844

Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AA

Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency

$616,825

Jean-Marc Schwarz · Touro University Of California · R01 · FY2017 · HL

Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes

Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies

Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota

Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota

Hereditary Genetics of Hepatocellular Carcinoma

Molecular and Clinical Studies of Insulin Resistance

Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

HIV Therapy & Interruption RCT in Resource Poor Clinic

Ethnicity and fat deposition in obesity-related disease in youth

Deep phenotyping of ANGPTL3, ANGPTL4 and ANGPTL8 human knockouts and population based studies

HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY

Non Alcoholic Steatohepatitis Clinical Research Network

Mass spectrometry for highly sensitive and sample-sparing analysis of extracellular vesicles in liver diseases

Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies

Randomized Trial of Diet in GDM: Metabolic Consequences to Mother and Offspring

Transgenerational obesity caused by ancestral exposure to obesogens in utero: changes in germline genomic architecture, roles of gonadal somatic cells, and metabolomic analysis of sexual dimorphism

Visceral Adiposity, HIV, and HCV: Biologic Mediators of Hepatic Steatosis

Novel roles of PDK4 in regulating mitochondrial protein phosphorylation, carbon flux and metabolic resilience

Effects of Macronutrients on Regulation of Endoplasmic Reticulum Stress in Human

Metabolic effects of adipose lipogenesis

Metabolic effects of adipose lipogenesis

Prenatal stress and diet, and the fetal epigenome

Perfluoroalkyl Substances and the Gut Microbiome and Fecal Metabolome: Implications for Obesity Risk in Hispanic Children

Heat shock protein 90 in alcoholic liver disease: targeting macrophage Function

Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency